Institutional experience on the impact of glucagon-like peptide-1 agonists (GLP-1) on glycemic control and weight loss in patients with type 2 diabetes at the Dubai Diabetes Center, United Arab Emirates

Dima Abdelmannan, A. Enrique Caballero, Heitham K. Ajlouni et al.|Diabetes Research and Clinical Practice|2023

Cited by 4